Editorial: Improvement of melanoma immune checkpoint blockade therapy with potential combinatorial regiments

By sjmartinez • November 18, 2022

Wang X, Liu X, Hugo W, Si L, Shi H. Editorial: Improvement of melanoma immune checkpoint blockade therapy with potential combinatorial regiments. Front Immunol. 2022 Oct 31;13:1065937. doi: 10.3389/fimmu.2022.1065937. PMID: 36389823; PMCID: PMC9661360.

Tags: Biomarker, combination therapy, Dermatology, immune checkpoint blockade (ICB), immune checkpoint inhibitors (ICIs), immune-related adverse events (irAEs), melanoma, Publications

Envudeucitinib, a Potent, Next-Generation, Allosteric Inhibitor of TYK2: A Narrative Review

Armstrong AW, Krueger JG, Strober BE, Stein Gold LF, Desai SR, Muscianisi E, Klyachkin Y, Ucpinar S, Tilley MK, Blauvelt A. Envudeucitinib, a Potent, Next-Generation,[...]

Incubating Artificial Intelligence (AI) Initiatives and Careers in Dermatology

Wongvibulsin S, Primiero CA, Adamson AS, Barata C, Betz-Stablein B, Celebi ME, Dawant B, Guitera P, Kelly KM, Kittler H, Kose K, Landman B, Lehman[...]

Neutrophil Transcriptomic Changes in Severe Sterile Vasoplegic Syndrome Resemble a Distinct Molecular Subtype of Septic Shock

Siletz AE, Kelly-Scumpia KM, Scumpia PO, Street K, Ragkousis V, Shirazi R, Sanaiha Y, Do TH, Shemin R, Kwon M, Crager S, Benharash P, Cryer[...]